Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Insulin costs drug makers only a few dollars to produce, but people with diabetes can end up spending thousands of dollars on insulin every month. A quarter of patients simply can't afford it at all.

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

The average monthly out-of-pocket cost for Lilly’s insulin is about $17, the spokesperson noted, adding that the company has ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

And in infamous cases, greedy CEOs have hiked prices figuring that desperate patients would have little choice but to purchase their products. Then there’s the case of insulin. No monopoly issue ...

The Federal Trade Commission on Friday filed an administrative complaint against the three largest pharmacy benefit managers and their affiliated group purchasing organizations, alleging they have ...

In response to public pressure and changing market dynamics, the trio of major manufacturers slashed insulin prices by 70% or ...

Travis Paulson looks at NovoRapid (Canada) and NovoLog (US), a replacement insulin drug at his house on January 16, 2020 in Eveleth, Minnesota. - It's the wealthiest country on the planet but the ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

It has also reported shortages of NovoLog, another insulin product. The drugmakers run patient assistance programs that cap ...